Key statistics
On Monday, Esperion Therapeutics Inc (ESPR:NMQ) closed at 1.63, 132.86% above the 52 week low of 0.70 set on Oct 12, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.70 |
---|---|
High | 1.71 |
Low | 1.63 |
Bid | 1.64 |
Offer | 1.65 |
Previous close | 1.68 |
Average volume | 3.33m |
---|---|
Shares outstanding | 196.22m |
Free float | 195.24m |
P/E (TTM) | -- |
Market cap | 329.66m USD |
EPS (TTM) | -0.8758 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 21:00 BST.
More ▼
- Esperion to Participate in Upcoming 2024 Cantor Global Healthcare Conference
- Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe)
- Esperion to Participate in Upcoming H.C. Wainwright 26th Annual Global Investment Conference
- Esperion Reports Second Quarter 2024 Financial Results and Provides a Business Update
- Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Esperion to Report Second Quarter 2024 Financial Results on August 12
- Esperion to Participate in Upcoming BTIG Biotech Conference
- New Digital First Marketing Campaign from Esperion Alerts Patients with Uncontrolled LDL Cholesterol to the “Lipid Lurkers” Inside Their Arteries
- Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest Facility
- Esperion to Participate in Upcoming June Investor Conferences
More ▼